Cargando…
Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
Solid lipid nanoparticles have been increasingly utilised for improving oral bioavailability of drugs. Simvastatin is biopharmaceutical class 2 drug with poor oral bioavailability of 5%. In the present study, simvastatin solid lipid nanoparticles were successfully prepared by hot melt emulsification...
Autores principales: | Padhye, S. G., Nagarsenker, Mangal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877522/ https://www.ncbi.nlm.nih.gov/pubmed/24403661 |
Ejemplares similares
-
Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
por: Patere, Shilpa N., et al.
Publicado: (2015) -
Stability Indicating RP-HPLC Method for Simultaneous Determination of Simvastatin and Ezetimibe from Tablet Dosage Form
por: Dixit, R. P., et al.
Publicado: (2010) -
A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
por: Kulkarni, Madhur, et al.
Publicado: (2008) -
Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders
por: Górniak, Agata, et al.
Publicado: (2023) -
Development and Evaluation of Artemether Parenteral Microemulsion
por: Tayade, N. G., et al.
Publicado: (2010)